Biomeme
Therapy Response Profile

TB-500
Recovery Response

TB-500 (synthetic Thymosin Beta-4) is primary in cellular motility, wound healing, and musculoskeletal regeneration. Transcriptomic tracking monitors cytoskeletal actin assembly and myogenic differentiation factors to quantify systemic repair.

Dashboard Integration

Tracked Physiological Dimensions

On the Advanced Transcriptomics Dashboard, TB-500 response is mapped directly to musculoskeletal structural repair indices.

Molecular Mechanism

Accelerating Cytoskeletal Assembly

TB-500's primary mechanism of action is its ability to sequester G-actin (monomeric actin). This drives the rapid assembly of F-actin (filamentous actin), providing cells with the physical structure required to migrate, divide, and bridge gaps at injury sites.

By tracking actin synthesis (ACTB) and myoblast mobilization markers (MYOD1), transcriptomics provides proof of physical tissue repair. This allows clinicians to monitor structural recovery kinetics and confirm that healing pathways are actively engaged.

Key Target Genes

ACTB
Actin Beta Cytoskeletal Structure

Drives actin polymerization, crucial for cell migration, cellular architecture, and tissue repair.

MYOD1
Myoblast Determination Protein 1 Satellite Cell Activation

Initiates skeletal muscle differentiation and satellite cell activation to repair microtears.

FGF2
Fibroblast Growth Factor 2 Growth Factor Signaling

Stimulates cell growth, vascular sprout formation, and tissue regeneration at injury sites.

MMP2 / MMP9
Matrix Metalloproteinases 2 & 9 Extracellular Remodeling

Temporarily remodel extracellular matrix to allow stem cells and growth factors to migrate.

Longitudinal Timeline

Expected mRNA Expression Timeline

A typical timeline showing how active gene expression signals evolve during a TB-500 therapy cycle.

Week 1

Matrix Mobilization

Upregulation of actin (ACTB) and matrix remodeling markers (MMPs) to facilitate cell migration.

Week 2–4

Myogenic Differentiation

Peak expression of MYOD1 signals active satellite cell fusion and muscle tissue repair.

Week 6+

Structural Consolidation

Restoration of baseline cytoskeletal transcription indicates structural integrity has been restored.

Enabling Technology

Point-of-Care Musculoskeletal Assays

Biomeme's platform offers immediate quantitative PCR tracking for satellite cell activation and muscle repair transcripts. Assess structural regeneration and recovery genes in under 15 minutes, processed via CLIA-certified One Health Labs.

The Science Behind the Data

Curious how we measure this?

Learn about the foundational science of Transcriptomics and how Biomeme brings molecular profiling to the point of need.

Ready to Learn More?

Explore how Biomeme's capabilities are being deployed across the Wellness landscape.